Peter Westervelt

Barnes-Jewish Hospital

Full Professor(heuristic)

Acute Myeloid Leukemia Research · Hematology

Compare more Hematology professors.

h-index90
i10-index190
Publications465
Citations63,087

Grants

5 total · 0 active

NIH #P01CA101937

Core A - Clinical Database.

Amount
$300K–$400K
Period
2003-09-19 → 2024-11-30
PIs
1

Awarded at WASHINGTON UNIVERSITY

NIH #UG1HL109137

A Phase II Study of Cytokine Induced Memory-like (CIML) Natural Killer (NK) Cell Adoptive Therapy after Haploidentical Donor Hematopoietic Cell Transplantation.

Amount
$100K–$200K
Period
2017-07-27 → 2024-06-30
PIs
1

Awarded at WASHINGTON UNIVERSITY

NIH #U10HL109137

Sargrastim and Plerixafor vs. Filgrastim for Allogeneic Stem Cell Mobilization

Amount
$100K–$200K
Period
2011-08-08 → 2017-06-30
PIs
1

Awarded at WASHINGTON UNIVERSITY

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

5 total · 0 active

NIH #P01CA101937

Core A - Clinical Database.

Amount
$300K–$400K
Period
2003-09-19 → 2024-11-30
PIs
1

Awarded at WASHINGTON UNIVERSITY

NIH #UG1HL109137

A Phase II Study of Cytokine Induced Memory-like (CIML) Natural Killer (NK) Cell Adoptive Therapy after Haploidentical Donor Hematopoietic Cell Transplantation.

Amount
$100K–$200K
Period
2017-07-27 → 2024-06-30
PIs
1

Awarded at WASHINGTON UNIVERSITY

NIH #U10HL109137

Sargrastim and Plerixafor vs. Filgrastim for Allogeneic Stem Cell Mobilization

Amount
$100K–$200K
Period
2011-08-08 → 2017-06-30
PIs
1

Awarded at WASHINGTON UNIVERSITY

NIH #K08HL003991

DEVELOPMENTAL TARGETING--PML RARA EXPRESSION IN VIVO

Amount
$100K–$200K
Period
1999-04-01 → 2004-03-31
PIs
1

Awarded at UNIV OF MASSACHUSETTS MED SCH WORCESTER

NIH #P50CA171963

Biospecimen Processing

Amount
$200K–$300K
Period
— → —
PIs
1

Awarded at WASHINGTON UNIVERSITY

Recent Public Signals

  1. New paper: Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment Trial (Blood Advances)2026-06-05
  2. New preprint: Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial2024-09-16

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-04

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

Professor Insights

Career Trajectory